AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.7590
-0.0038 (-0.50%)
At close: Jun 27, 2025, 4:00 PM
0.7413
-0.0177 (-2.33%)
After-hours: Jun 27, 2025, 5:40 PM EDT
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $8.58 million as of June 27, 2025. Its market cap has decreased by -86.94% in one year.
Market Cap
8.58M
Enterprise Value
12.78M
1-Year Change
-86.94%
Ranking
Category
Stock Price
$0.76
Market Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $8.58M, a decrease of -86.52%. That is a compound annual growth rate of -37.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 8.62M | -60.05% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 698.51B |
| Johnson & Johnson | 366.18B |
| AbbVie | 327.76B |
| Novo Nordisk | 313.40B |
| UnitedHealth Group | 277.24B |
| Abbott Laboratories | 240.24B |
| Novartis AG | 232.39B |
| AstraZeneca | 218.32B |